BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7031669)

  • 1. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
    Ostrand-Rosenberg S; Cohn A
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
    Ostrand-Rosenberg S; Cohan VL
    J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.
    Ostrand-Rosenberg S; Clements V
    Immunogenetics; 1987; 26(1-2):1-5. PubMed ID: 3301646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.
    Ostrand-Rosenberg S; Cole GA; Nishimura MI; Clements VK
    Cell Immunol; 1990 Jun; 128(1):152-64. PubMed ID: 2344619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor.
    Ostrand-Rosenberg S; Schwartzman ML; Hecht TT; Marr L
    Cell Immunol; 1986 May; 99(2):453-60. PubMed ID: 3093106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cells.
    Ostrand-Rosenberg S; Clements V; Marr L
    Cell Immunol; 1986 Apr; 98(2):257-65. PubMed ID: 3093094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of major histocompatibility gene expression in teratocarcinoma 402AX cells.
    Ostrand-Rosenberg S; Clements V; Cole G; DeCloux A; Marr L; Schwartzman M
    Cell Differ; 1984 Dec; 15(2-4):221-7. PubMed ID: 6336034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection.
    Ostrand-Rosenberg S; Clements VK; Thakur A; Cole GA
    J Immunogenet; 1989; 16(4-5):343-9. PubMed ID: 2639907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
    Miller SC
    J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique killing of embryo-derived teratocarcinoma cells by nonactivated murine macrophages is not due to a lack of H-2 antigen expression.
    Sionov RV; Gallily R
    Cell Immunol; 1992 Jul; 142(2):416-25. PubMed ID: 1623557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratocarcinoma transplantation antigens are encoded in the H-2 region.
    Johnson LL; Clipson LJ; Dove WF; Feilbach J; Maher LJ; Shedlovsky A
    Immunogenetics; 1983; 18(2):137-45. PubMed ID: 6350173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface antigens of a mouse testicular teratoma. Identification of an antigen physically associated with H-2 antigens on tumor cells.
    Gooding LR; Edidin M
    J Exp Med; 1974 Jul; 140(1):61-78. PubMed ID: 4365513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to murine 402AX teratocarcinoma: regulation by H-2IA and H-3 to H-13 region genes.
    Ostrand-Rosenberg S; McCarthy C
    Immunogenetics; 1984; 19(1):77-82. PubMed ID: 6693137
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
    Bartlett PF; Fenderson BA; Edidin M
    J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
    Miller SC
    Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.
    Shedlovsky A; Clipson LJ; VandeBerg JL; Dove WF
    Immunogenetics; 1981; 13(5):413-9. PubMed ID: 7298086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental potentialities and surface antigens of mouse teratocarcinoma x lymphoid cell hybrids.
    Rousset JP; Jami J; Dubois P; Avilès D; Ritz E
    Somatic Cell Genet; 1980 May; 6(3):419-33. PubMed ID: 7404272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of MHC antigens by human teratocarcinoma derived cell lines.
    Andrews PW; Bronson DL; Wiles MV; Goodfellow PN
    Tissue Antigens; 1981 May; 17(5):493-500. PubMed ID: 7199768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.